Interpace Biosciences Inc Est. EPS Q / Q
Mi az Interpace Biosciences Inc Est. EPS Q / Q?
A Est. EPS Q / Q az Interpace Biosciences Inc - -92.22%
Mi a Est. EPS Q / Q meghatározása?
A várható EPS negyedévenkénti növekedési üteme évről évre meghaladja a vállalat EPS-jének becsült növekedését a következő negyedévben az előző negyedévhez képest.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q a Health Care szektor a NASDAQ-on cégekben a Interpace Biosciences Inc -hoz képest
Mit csinál Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
est. eps q / q -hoz hasonló cégek Interpace Biosciences Inc
- Acadia Realty Trust nak Est. EPS Q / Q -92.31% van
- Medicure nak Est. EPS Q / Q -92.31% van
- DHT Inc nak Est. EPS Q / Q -92.31% van
- Aleafia Health Inc nak Est. EPS Q / Q -92.31% van
- Acacia Research Corp nak Est. EPS Q / Q -92.31% van
- SOC Telemed nak Est. EPS Q / Q -92.27% van
- Interpace Biosciences Inc nak Est. EPS Q / Q -92.22% van
- Independence Contract Drilling Inc nak Est. EPS Q / Q -91.85% van
- Frontera nak Est. EPS Q / Q -91.75% van
- Penumbra Inc nak Est. EPS Q / Q -91.67% van
- OrganiGram nak Est. EPS Q / Q -91.67% van
- ShiftPixy Inc nak Est. EPS Q / Q -91.67% van
- Smartsheet Inc nak Est. EPS Q / Q -91.67% van